These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 29997457

  • 1. Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study.
    Majeed M, Nagabhushanam K, Arumugam S, Majeed S, Ali F.
    Food Nutr Res; 2018; 62():. PubMed ID: 29997457
    [Abstract] [Full Text] [Related]

  • 2. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study.
    Majeed M, Nagabhushanam K, Natarajan S, Sivakumar A, Ali F, Pande A, Majeed S, Karri SK.
    Nutr J; 2016 Feb 27; 15():21. PubMed ID: 26922379
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant].
    Gupta AK, Maity C.
    Medicine (Baltimore); 2021 Jan 22; 100(3):e23641. PubMed ID: 33545934
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study.
    Sudha MR, Jayanthi N, Aasin M, Dhanashri RD, Anirudh T.
    Benef Microbes; 2018 Jun 15; 9(4):563-572. PubMed ID: 29695183
    [Abstract] [Full Text] [Related]

  • 5. The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome-A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial.
    Skrzydło-Radomańska B, Prozorow-Król B, Kurzeja-Mirosław A, Cichoż-Lach H, Laskowska K, Majsiak E, Bierła JB, Agnieszka S, Cukrowska B.
    J Clin Med; 2023 Jul 22; 12(14):. PubMed ID: 37510953
    [Abstract] [Full Text] [Related]

  • 6. The effects of Bacillus coagulans MTCC 5856 on functional gas and bloating in adults: A randomized, double-blind, placebo-controlled study.
    Majeed M, Nagabhushanam K, Paulose S, Arumugam S, Mundkur L.
    Medicine (Baltimore); 2023 Mar 03; 102(9):e33109. PubMed ID: 36862903
    [Abstract] [Full Text] [Related]

  • 7. The role of Weizmannia (Bacillus) coagulans LMG S-31876 in treating IBS-diarrhea.
    Kallur RK, Madapati S, Mathur A, Bhattacharya S.
    Front Nutr; 2023 Mar 03; 10():1310462. PubMed ID: 38375355
    [Abstract] [Full Text] [Related]

  • 8. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults.
    Madempudi RS, Ahire JJ, Neelamraju J, Tripathi A, Nanal S.
    Sci Rep; 2019 Aug 21; 9(1):12210. PubMed ID: 31434935
    [Abstract] [Full Text] [Related]

  • 9. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    Xie P, Luo M, Deng X, Fan J, Xiong L.
    Nutrients; 2023 Sep 04; 15(17):. PubMed ID: 37686889
    [Abstract] [Full Text] [Related]

  • 10. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
    Urgesi R, Casale C, Pistelli R, Rapaccini GL, de Vitis I.
    Eur Rev Med Pharmacol Sci; 2014 Sep 04; 18(9):1344-53. PubMed ID: 24867512
    [Abstract] [Full Text] [Related]

  • 11. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
    Dolin BJ.
    Methods Find Exp Clin Pharmacol; 2009 Dec 04; 31(10):655-9. PubMed ID: 20140275
    [Abstract] [Full Text] [Related]

  • 12. Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, placebo-controlled clinical trial.
    Shaikh SS, Kumar S.
    Medicine (Baltimore); 2024 Aug 02; 103(31):e39134. PubMed ID: 39093754
    [Abstract] [Full Text] [Related]

  • 13. Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management?
    Abhari K, Saadati S, Hosseini-Oskouiee F, Yari Z, Hosseini H, Sohrab G, Hejazi E, Agah S, Sadeghi A, Hekmatdoost A.
    Eur J Nutr; 2020 Aug 02; 59(5):2111-2117. PubMed ID: 31327047
    [Abstract] [Full Text] [Related]

  • 14. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun 02; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

  • 15. Probiotic Weizmannia coagulans MTCC 5856 as adjunct therapy in children's acute diarrhea-a randomized, double-blind, placebo-controlled study.
    Majeed M, Nagabhushanam K, Arumugam S, Chadalavada N, Seepana J, Annamalai T, Murali A, Prakasan P, Mundkur L.
    Front Pediatr; 2023 Jun 02; 11():1338126. PubMed ID: 38269290
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.
    Dapoigny M, Piche T, Ducrotte P, Lunaud B, Cardot JM, Bernalier-Donadille A.
    World J Gastroenterol; 2012 May 07; 18(17):2067-75. PubMed ID: 22563194
    [Abstract] [Full Text] [Related]

  • 17. Probiotic modulation of gut microbiota by Bacillus coagulans MTCC 5856 in healthy subjects: A randomized, double-blind, placebo-control study.
    Majeed M, Nagabhushanam K, Mundkur L, Paulose S, Divakar H, Rao S, Arumugam S.
    Medicine (Baltimore); 2023 May 19; 102(20):e33751. PubMed ID: 37335737
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
    Lewis-Fernández R, Lam P, Lucak S, Galfalvy H, Jackson E, Fried J, Rosario M, de la Cruz AA, Sánchez-Lacay A, Díaz S, Schneier F.
    J Clin Psychopharmacol; 2016 Dec 19; 36(6):710-715. PubMed ID: 27755218
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    Zhang T, Zhang C, Zhang J, Sun F, Duan L.
    Front Cell Infect Microbiol; 2022 Dec 19; 12():859967. PubMed ID: 35433498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.